• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BCI-215 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5752468

BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BCI-215, Inhibitor
Full Product Name
BCI-215
Product Gene Name
Form/Format
Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.
Molecular Weight
396.3
Formula
C22H22BrNO
CAS
1245792-67-9
Smiles
Brc1ccc2C(=O)\C(C(NC3CCCCC3)c2c1)=C\c1ccccc1
Solubility
(<1mg/ml refers to the product slightly soluble or insoluble)

Product Categories/Family for BCI-215, inhibitor

Structure of BCI-215, inhibitor

BCI-215 Inhibitor – Cat# MBS5752468

Product References and Citations for BCI-215, inhibitor

1. Kaltenmeier C T, Vollmer L L, Vernetti L A, et al. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 361 (1):39-50.
2. Kaltenmeier C T, Vollmer L L, Vernetti L A, et al. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity[J]. Journal of Pharmacology and Experimental Therapeutics, 2017, 361 (1):39-50.

Other Notes

Small volumes of BCI-215, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BCI-215 purchase

MBS5752468 is an inhibitor targeting BCI-215.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000